Non-hemorrhage | Hemorrhage | P value | |
(n=798) | (n=61) | ||
Age (years) | 57 (50–65) | 56 (48–65) | 0.478* |
Male, n (%) | 572/798 (71.7) | 47/61 (77.0) | 0.368† |
Risk factor, n (%) | |||
Smoking | 378/798 (47.4) | 33/61 (54.1) | 0.310† |
Alcohol intake | 326/798 (40.9) | 29/61 (47.5) | 0.307† |
History of stroke/TIA | 144/798 (18.0) | 13/61 (21.3) | 0.525† |
Hypertension | 522/798 (65.4) | 42/61 (68.9) | 0.586† |
Diabetes mellitus | 180/798 (22.6) | 20/61 (32.8) | 0.068† |
Hyperlipidemia | 88/798 (11.0) | 8/61 (13.1) | 0.631† |
Coronary heart disease | 66/798 (8.3) | 7/61 (11.5) | 0.387† |
Statin therapy, n (%) | |||
Prior statin | 90/798 (11.3) | 8/61 (13.1) | 0.679† |
Present intensive statin | 289/798 (36.2) | 28/61 (45.9) | 0.126† |
Scale score | |||
NIHSS | 3 (1–5) | 4 (2–9) | 0.009* |
Infarction cause, n (%) | 0.081† | ||
LAA | 201/720 (27.9) | 24/61 (39.3) | |
SAO | 322/720 (44.7) | 19/61 (31.1) | |
SOE and SUE | 197/720 (27.4) | 18/61 (29.5) | |
Infarction distribution, n (%) | 0.060† | ||
Anterior circulation | 196/720 (27.2) | 24/61 (39.3) | |
Posterior circulation | 327/720 (45.4) | 19/61 (31.1) | |
Anterior and posterior circulation | 197/720 (27.4) | 18/61 (29.5) |
Categorical variables are presented as n (%), and continuous variables are presented as the median (IQR); p<0.05 was considered statistically significant.
*P value obtained by Mann–Whitney U test.
†P value obtained by χ 2 test.
SOE stroke of other determined etiology; LAA, large artery atherosclerosis; NIHSS, National Institutes of Health Stroke Scale; SAO, small artery occlusion; SUE, stroke of undetermined etiology; TIA, transient ischemic attack.